A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

NCT06854640 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer